P

Inventor

HORNBERGER KEITH R

US20 patents
⚠️ This page may combine multiple inventors who share the name “HORNBERGER KEITH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARVINAS OPERATIONS INC

15 patents
US11104666B2Aug 31, 2021

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC18 citations94
US11173211B2Nov 16, 2021

Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides

ARVINAS OPERATIONS INC6 citations84
US12077509B2Sep 3, 2024

Compounds and methods for the targeted degradation of androgen receptor

ARVINAS OPERATIONS INC1 citations73
US11964945B2Apr 23, 2024

Compounds and methods for the targeted degradation of androgen receptor

ARVINAS OPERATIONS INC2 citations73
US11161841B2Nov 2, 2021

Modulators of proteolysis and associated methods of use

ARVINAS OPERATIONS INC3 citations73
US12552783B2Feb 17, 2026

Modulators of proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US12275716B2Apr 15, 2025

Modulators of estrogen receptor proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025

Cereblon ligands and bifunctional compounds comprising the same

ARVINAS OPERATIONS INC0 citations62
US12180193B2Dec 31, 2024

Accelerating fibrosarcoma protein degrading compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations62
US12172981B2Dec 24, 2024

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

ARVINAS OPERATIONS INC0 citations62
US11986531B2May 21, 2024

Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

ARVINAS OPERATIONS INC0 citations62
US12156916B2Dec 3, 2024

Rapid accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations61
US11957759B1Apr 16, 2024

Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations61
US10806737B2Oct 20, 2020

Compounds and methods for the targeted degradation of fetal liver kinase polypeptides

ARVINAS OPERATIONS INC2 citations60
US12441708B2Oct 14, 2025

Cereblon ligands and bifunctional compounds comprising the same

ARVINAS OPERATIONS INC0 citations52

ARVINAS INC

2 patents

BOEHRINGER INGELHEIM INT

2 patents

OSI PHARMACEUTICALS LLC

1 patent